Axis II: Personality disorder (ex: borderline personality disorder) or mental retardation Axis III: Medical problems (only MDs can diagnose these) Axis IV: Psychosocial and Environmental Problems Axis V: Global assessment of functioning (GAF) is a numerical rating on a scale of 0 - 100 of the client's current functioning with the life stressors he or she presents with.
The Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Axis II, Fourth Edition (DSM-IV-R) (SCID-II) [ 29] is used for assessing Axis II personality disorders and severity of personality problems.
The structured clinical interview for the diagnostic and statistical manual of mental disorders, axis II (SCID-II) The SCID II [ 29] is a version of the SCID developed for the assessment of DSM-IV-TR Personality Disorders.
Volunteers suffering from a current mental disorder (axis I/II), including substance dependence or abuse, as assessed using the German Version of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders-IV [SCID I (Wittchen et al. 1997)], were excluded from the study.
These key informants reported that referrals to mental health for Axis II (i.e., personality disorder) patients were commonly rejected.
Mental disorders on Axis I and II are assessed using face-to-face diagnostic interviews (Strukturiertes Klinisches Interview für DSM, SKID-I/II; [ 62]).
Two population 'norms' were used for comparison, the first was from a similar population of clients with a major mental disorder, primarily Axis 1 diagnoses, 70% of whom had a diagnosis of Schizophrenia [ 55].
The results of these studies may not generalize to individuals with fibromyalgia symptoms diagnosed with Diagnostic and Statistical Manual of Mental Disorders-IV axis-one psychiatric disorder, rheumatic disease, or treatment-resistant patients, because such patients were excluded from the studies.
An open trial design was used to examine the implementation and effectiveness of a cognitive behavioral intervention (Seeking Safety) for comorbid post-traumatic stress disorder (PTSD) and substance use disorder (SUD) for incarcerated women with Axis I mental disorders who self-referred for specialty trauma treatment.
Genomic DNA from control subjects were obtained from the NIMH Genetics Initiative Control sample set (n = 1161); these subjects were screened for any Axis I mental health disorders and none had a diagnosis of autism.
